Literature DB >> 23611359

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.

Alexandra Traverse-Glehen1, Emmanuel Bachy, Lucile Baseggio, Evelyne Callet-Bauchu, Sophie Gazzo, Aurélie Verney, Sandrine Hayette, Laurent Jallades, Martine Ffrench, Gilles Salles, Bertrand Coiffier, Pascale Felman, Francoise Berger.   

Abstract

AIMS: To describe 76 cases of splenic marginal zone lymphoma (SMZL), including correlations with clinical and other characteristics. METHODS AND
RESULTS: Patients were predominantly female, with a median age of 62 years. The main clinical presentation was splenomegaly, except for eight cases presenting with evolution of autoimmune disorders or spontaneous splenic rupture. White pulp infiltration was nodular, with a monophasic (42%) or biphasic (53%) pattern, and associated diffuse or nodular infiltration of the red pulp, except for four cases which had atrophic white pulp. Plasmacytic differentiation and the MYD88 L265P mutation were observed in 18% and 5% of the cases, respectively. Histological progression was considered in cases with a significant association of large cells with Ki67 > 30% and macronodular architecture (P = 0.001). Other significant correlations were found between del7q (44%) and del6q (17%) (P = 0.018), IGHV1-2*04 segment usage (35%) (P = 0.001) and unmutated IGHV (39%) (P = 0.019), and between CD5 expression (27%) and higher lymphocytosis (P = 0.002). Patients requiring intensive chemotherapy after splenectomy because of clinical and/or histological progression had significantly shorter overall survival (P = 0.012).
CONCLUSIONS: We report the histological spectrum of SMZL, and discuss the differential diagnosis and requirement for molecular and cytogenetic analysis in atypical cases.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23611359     DOI: 10.1111/his.12092

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.

Authors:  Eleonora Fonte; Andreas Agathangelidis; Daniele Reverberi; Stavroula Ntoufa; Lydia Scarfò; Pamela Ranghetti; Giovanna Cutrona; Alessandra Tedeschi; Aliki Xochelli; Federico Caligaris-Cappio; Maurilio Ponzoni; Chrysoula Belessi; Zadie Davis; Miguel A Piris; David Oscier; Paolo Ghia; Kostas Stamatopoulos; Marta Muzio
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

2.  A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.

Authors:  Gabriel Brisou; Aurélie Verney; Thomas Wenner; Lucile Baseggio; Pascale Felman; Evelyne Callet-Bauchu; Bertrand Coiffier; Françoise Berger; Gilles Salles; Alexandra Traverse-Glehen
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

Review 3.  Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA.

Authors:  Jacob E Robinson; Christine E Cutucache
Journal:  Oncotarget       Date:  2018-07-06

Review 4.  MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications.

Authors:  Ruben A L de Groen; Anne M R Schrader; Marie José Kersten; Steven T Pals; Joost S P Vermaat
Journal:  Haematologica       Date:  2019-11-07       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.